Cogent Biosciences Inc
NASDAQ:COGT

Watchlist Manager
Cogent Biosciences Inc Logo
Cogent Biosciences Inc
NASDAQ:COGT
Watchlist
Price: 39.55 USD 4.35% Market Closed
Market Cap: 5.5B USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of COGT.

The Intrinsic Value is calculated as the average of DCF and Relative values:

COGT Intrinsic Value
Not Available
Base Case Scenario
Compare COGT to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about COGT?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cogent Biosciences Inc

Current Assets 397.2m
Cash & Short-Term Investments 390.9m
Other Current Assets 6.4m
Non-Current Assets 28.7m
PP&E 23.9m
Other Non-Current Assets 4.8m
Current Liabilities 62.2m
Accounts Payable 16m
Accrued Liabilities 44.9m
Other Current Liabilities 1.3m
Non-Current Liabilities 61.2m
Long-Term Debt 44.3m
Other Non-Current Liabilities 17m
Efficiency

Free Cash Flow Analysis
Cogent Biosciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cogent Biosciences Inc

Revenue
0 USD
Operating Expenses
-307.6m USD
Operating Income
-307.6m USD
Other Expenses
92.8m USD
Net Income
-214.8m USD
Fundamental Scores

COGT Profitability Score
Profitability Due Diligence

Cogent Biosciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
hidden
Profitability
Score

Cogent Biosciences Inc's profitability score is hidden . The higher the profitability score, the more profitable the company is.

COGT Solvency Score
Solvency Due Diligence

Cogent Biosciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
hidden
Solvency
Score

Cogent Biosciences Inc's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

COGT Price Targets Summary
Cogent Biosciences Inc

Wall Street analysts forecast COGT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COGT is 50.07 USD with a low forecast of 34.34 USD and a high forecast of 70.35 USD.

Lowest
Price Target
34.34 USD
13% Downside
Average
Price Target
50.07 USD
27% Upside
Highest
Price Target
70.35 USD
78% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cogent Biosciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for COGT is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

COGT Insider Trading
Buy and sell transactions by insiders